| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T25 |
6-7 |
-LRB- |
denotes |
( |
| T26 |
7-11 |
NNS |
denotes |
CoVs |
| T27 |
11-12 |
-RRB- |
denotes |
) |
| T28 |
13-16 |
VBP |
denotes |
are |
| T29 |
17-25 |
JJ |
denotes |
zoonotic |
| T30 |
26-35 |
NNS |
denotes |
pathogens |
| T31 |
36-40 |
IN |
denotes |
with |
| T32 |
41-45 |
JJ |
denotes |
high |
| T33 |
46-54 |
NN |
denotes |
fatality |
| T34 |
55-60 |
NNS |
denotes |
rates |
| T35 |
61-64 |
CC |
denotes |
and |
| T36 |
65-73 |
JJ |
denotes |
pandemic |
| T37 |
74-83 |
NN |
denotes |
potential |
| T38 |
85-92 |
NN |
denotes |
Vaccine |
| T39 |
93-104 |
NN |
denotes |
development |
| T40 |
105-112 |
VBZ |
denotes |
focuses |
| T41 |
113-115 |
IN |
denotes |
on |
| T42 |
116-119 |
DT |
denotes |
the |
| T43 |
120-129 |
JJ |
denotes |
principal |
| T44 |
130-136 |
NN |
denotes |
target |
| T45 |
137-139 |
IN |
denotes |
of |
| T46 |
140-143 |
DT |
denotes |
the |
| T47 |
144-156 |
VBG |
denotes |
neutralizing |
| T48 |
157-164 |
JJ |
denotes |
humoral |
| T49 |
165-171 |
JJ |
denotes |
immune |
| T50 |
172-180 |
NN |
denotes |
response |
| T51 |
180-181 |
-COMMA- |
denotes |
, |
| T52 |
182-185 |
DT |
denotes |
the |
| T53 |
186-191 |
NN |
denotes |
spike |
| T54 |
192-193 |
-LRB- |
denotes |
( |
| T55 |
193-194 |
NN |
denotes |
S |
| T56 |
194-195 |
-RRB- |
denotes |
) |
| T57 |
196-208 |
NN |
denotes |
glycoprotein |
| T58 |
210-221 |
NN |
denotes |
Coronavirus |
| T59 |
222-223 |
NN |
denotes |
S |
| T60 |
224-232 |
NNS |
denotes |
proteins |
| T61 |
233-236 |
VBP |
denotes |
are |
| T62 |
237-248 |
RB |
denotes |
extensively |
| T63 |
249-261 |
VBN |
denotes |
glycosylated |
| T64 |
261-262 |
-COMMA- |
denotes |
, |
| T65 |
263-271 |
VBG |
denotes |
encoding |
| T66 |
272-278 |
IN |
denotes |
around |
| T67 |
279-284 |
CD |
denotes |
66–87 |
| T68 |
285-293 |
JJ |
denotes |
N-linked |
| T69 |
294-307 |
NN |
denotes |
glycosylation |
| T70 |
308-313 |
NNS |
denotes |
sites |
| T71 |
314-317 |
IN |
denotes |
per |
| T72 |
318-326 |
JJ |
denotes |
trimeric |
| T73 |
327-332 |
NN |
denotes |
spike |
| T74 |
334-338 |
RB |
denotes |
Here |
| T75 |
338-339 |
-COMMA- |
denotes |
, |
| T76 |
340-342 |
PRP |
denotes |
we |
| T77 |
343-349 |
VBP |
denotes |
reveal |
| T78 |
350-351 |
DT |
denotes |
a |
| T79 |
352-360 |
JJ |
denotes |
specific |
| T80 |
361-365 |
NN |
denotes |
area |
| T81 |
366-368 |
IN |
denotes |
of |
| T82 |
369-373 |
JJ |
denotes |
high |
| T83 |
374-380 |
NN |
denotes |
glycan |
| T84 |
381-388 |
NN |
denotes |
density |
| T85 |
389-391 |
IN |
denotes |
on |
| T86 |
392-396 |
NNP |
denotes |
MERS |
| T87 |
397-398 |
NNP |
denotes |
S |
| T88 |
399-403 |
WDT |
denotes |
that |
| T89 |
404-411 |
VBZ |
denotes |
results |
| T90 |
412-414 |
IN |
denotes |
in |
| T91 |
415-418 |
DT |
denotes |
the |
| T92 |
419-428 |
NN |
denotes |
formation |
| T93 |
429-431 |
IN |
denotes |
of |
| R23 |
T26 |
T25 |
arg2Of |
CoVs,( |
| R24 |
T27 |
T25 |
arg3Of |
),( |
| R26 |
T30 |
T28 |
arg2Of |
pathogens,are |
| R27 |
T30 |
T29 |
arg1Of |
pathogens,zoonotic |
| R28 |
T30 |
T31 |
arg1Of |
pathogens,with |
| R29 |
T35 |
T31 |
arg2Of |
and,with |
| R30 |
T34 |
T32 |
arg1Of |
rates,high |
| R31 |
T34 |
T33 |
arg1Of |
rates,fatality |
| R32 |
T34 |
T35 |
arg1Of |
rates,and |
| R33 |
T37 |
T35 |
arg2Of |
potential,and |
| R34 |
T37 |
T36 |
arg1Of |
potential,pandemic |
| R35 |
T39 |
T38 |
arg1Of |
development,Vaccine |
| R36 |
T39 |
T40 |
arg1Of |
development,focuses |
| R37 |
T40 |
T41 |
arg1Of |
focuses,on |
| R38 |
T44 |
T41 |
arg2Of |
target,on |
| R39 |
T44 |
T42 |
arg1Of |
target,the |
| R40 |
T44 |
T43 |
arg1Of |
target,principal |
| R41 |
T44 |
T45 |
arg1Of |
target,of |
| R42 |
T50 |
T45 |
arg2Of |
response,of |
| R43 |
T50 |
T46 |
arg1Of |
response,the |
| R44 |
T50 |
T47 |
arg1Of |
response,neutralizing |
| R45 |
T50 |
T48 |
arg1Of |
response,humoral |
| R46 |
T50 |
T49 |
arg1Of |
response,immune |
| R47 |
T50 |
T51 |
arg1Of |
response,"," |
| R48 |
T57 |
T51 |
arg2Of |
glycoprotein,"," |
| R49 |
T57 |
T52 |
arg1Of |
glycoprotein,the |
| R50 |
T57 |
T53 |
arg1Of |
glycoprotein,spike |
| R51 |
T53 |
T54 |
arg1Of |
spike,( |
| R52 |
T55 |
T54 |
arg2Of |
S,( |
| R53 |
T56 |
T54 |
arg3Of |
),( |
| R54 |
T60 |
T58 |
arg1Of |
proteins,Coronavirus |
| R55 |
T60 |
T59 |
arg1Of |
proteins,S |
| R56 |
T60 |
T61 |
arg1Of |
proteins,are |
| R57 |
T63 |
T61 |
arg2Of |
glycosylated,are |
| R58 |
T63 |
T62 |
arg1Of |
glycosylated,extensively |
| R59 |
T60 |
T63 |
arg2Of |
proteins,glycosylated |
| R60 |
T63 |
T64 |
arg1Of |
glycosylated,"," |
| R61 |
T60 |
T65 |
arg1Of |
proteins,encoding |
| R62 |
T70 |
T65 |
arg2Of |
sites,encoding |
| R63 |
T63 |
T65 |
modOf |
glycosylated,encoding |
| R64 |
T70 |
T66 |
arg1Of |
sites,around |
| R65 |
T70 |
T67 |
arg1Of |
sites,66–87 |
| R66 |
T70 |
T68 |
arg1Of |
sites,N-linked |
| R67 |
T70 |
T69 |
arg1Of |
sites,glycosylation |
| R68 |
T70 |
T71 |
arg1Of |
sites,per |
| R69 |
T73 |
T71 |
arg2Of |
spike,per |
| R70 |
T73 |
T72 |
arg1Of |
spike,trimeric |
| R71 |
T77 |
T74 |
arg1Of |
reveal,Here |
| R72 |
T77 |
T75 |
arg1Of |
reveal,"," |
| R73 |
T76 |
T77 |
arg1Of |
we,reveal |
| R74 |
T80 |
T77 |
arg2Of |
area,reveal |
| R75 |
T80 |
T78 |
arg1Of |
area,a |
| R76 |
T80 |
T79 |
arg1Of |
area,specific |
| R77 |
T80 |
T81 |
arg1Of |
area,of |
| R78 |
T84 |
T81 |
arg2Of |
density,of |
| R79 |
T84 |
T82 |
arg1Of |
density,high |
| R80 |
T84 |
T83 |
arg1Of |
density,glycan |
| R81 |
T80 |
T85 |
arg1Of |
area,on |
| R82 |
T87 |
T85 |
arg2Of |
S,on |
| R83 |
T87 |
T86 |
arg1Of |
S,MERS |
| R84 |
T80 |
T88 |
arg1Of |
area,that |
| R85 |
T80 |
T89 |
arg1Of |
area,results |
| R86 |
T89 |
T90 |
arg1Of |
results,in |
| R87 |
T92 |
T90 |
arg2Of |
formation,in |
| R88 |
T92 |
T91 |
arg1Of |
formation,the |
| R89 |
T92 |
T93 |
arg1Of |
formation,of |